Detection and characterization of extended-spectrum β-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002

被引:60
作者
Ho, PL
Shek, RHL
Chow, KH
Duan, RS
Mak, GC
Lai, EL
Yam, WC
Tsang, KW
Lai, WM
机构
[1] United Christian Hosp, Dept Microbiol, Div Infect Dis, Hong Kong, Hong Kong, Peoples R China
[2] United Christian Hosp, Ctr Infect, Hong Kong, Hong Kong, Peoples R China
[3] United Christian Hosp, Dept Clin Pathol, Hong Kong, Hong Kong, Peoples R China
[4] Univ Hong Kong, Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China
关键词
cephalosporin resistance; ESBLs; CTX-M enzymes;
D O I
10.1093/jac/dki010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: A total of 139 consecutive and non-duplicate bloodstream isolates of Enterobacter spp. collected from inpatients in Hong Kong during 2000-2002 were studied for production of extended-spectrum beta-lactamases (ESBLs). Methods: All isolates were evaluated by the modified double-disc synergy test (m-DDST), the combined disc method (CDM) and the three-dimensional (3D) test. The m-DDST and CDM were modified by the use of cefepime discs. beta-Lactamases were characterized by isoelectric focusing and PCR sequencing using specific primers. Results: ESBLs were identified in nine isolates (overall 6.5%), including seven of 39 (17.9%) Enterobacter hormaechei, one of 27 (3.7%) Enterobacter aerogenes and the only Enterobacter intermedius strain. The E. intermedius strain was positive only in the 3D test but not in the other two tests. The other eight strains were positive in all three tests. No ESBL was detected in the other species, including non-hormaechei members of the Enterobacter cloacae complex (n=61), Enterobacter agglomerans (n=7), Enterobacter gergoviae (n=4) and Enterobacter sakazakii (n=1). The ESBL content included five different CTX-M enzymes (CTX-M-9, CTX-M-13, CTX-M-14, CTX-M-24 and a novel CTX-M-2-like beta-lactamase), SHV-12 (n=2) and unidentifiable ESBLs with a pI of 7.7 or 7.9 in two strains. The seven ESBL-producing E. hormaechei were genotyped by pulsed-field gel electrophoresis and were found to be unrelated to each other. In three of the CTX-M-producing strains, ISEcp1-like elements, including promoters for the beta-lactamase gene, were found. Conclusions: Our data underscore the diversity of CTX-M enzymes among Enterobacter spp. in Hong Kong.
引用
收藏
页码:326 / 332
页数:7
相关论文
共 35 条
  • [1] ABBOTT SL, 2003, MANUAL CLIN MICROBIO, P684
  • [2] A STANDARD NUMBERING SCHEME FOR THE CLASS-A BETA-LACTAMASES
    AMBLER, RP
    COULSON, AFW
    FRERE, JM
    GHUYSEN, JM
    JORIS, B
    FORSMAN, M
    LEVESQUE, RC
    TIRABY, G
    WALEY, SG
    [J]. BIOCHEMICAL JOURNAL, 1991, 276 : 269 - 270
  • [3] [Anonymous], 2002, M100S12 NCCLS
  • [4] [Anonymous], M39A NCCLS
  • [5] Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes
    Bonnet, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) : 1 - 14
  • [6] TAXONOMIC DIVERSITY OF ANAEROBIC GLYCEROL DISSIMILATION IN THE ENTEROBACTERIACEAE
    BOUVET, OMM
    LENORMAND, P
    AGERON, E
    GRIMONT, PAD
    [J]. RESEARCH IN MICROBIOLOGY, 1995, 146 (04) : 279 - 290
  • [7] β-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals
    Briñas, L
    Zarazaga, M
    Sáenz, Y
    Ruiz-Larrea, F
    Torres, C
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (10) : 3156 - 3163
  • [8] Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China
    Chanawong, A
    M'Zali, FH
    Heritage, J
    Xiong, JH
    Hawkey, PM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) : 630 - 637
  • [9] SHV-12, SHV-5, SHV-2a and VEB-1 extended-spectrum β-lactamases in Gram-negative bacteria isolated in a university hospital in Thailand
    Chanawong, A
    M'Zali, FH
    Heritage, J
    Lulitanond, A
    Hawkey, PM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (06) : 839 - 852
  • [10] A nosocomial outbreak due to Enterobacter cloacae strains with the E-hormaechei genotype in patients treated with fluoroquinolones
    DavinRegli, A
    Bosi, C
    Charrel, R
    Ageron, E
    Papazian, L
    Grimont, PAD
    Cremieux, A
    Bollet, C
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (04) : 1008 - 1010